Open AccessHigh SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Publication year - 2022
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2021.w30122
Subject(s) - seroprevalence , medicine , covid-19 , cross sectional study , disease , population , agonist , immunology , antibody , environmental health , infectious disease (medical specialty) , serology , pathology , receptor